rs9364554
| Orientation | plus |
| Stabilized | plus |
| Make rs9364554(C;C) |
| Make rs9364554(C;T) |
| Make rs9364554(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 6 |
| Position | 160412632 |
| Gene | SLC22A3 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs9364554 |
| dbSNP (classic) | rs9364554 |
| ClinGen | rs9364554 |
| ebi | rs9364554 |
| HLI | rs9364554 |
| Exac | rs9364554 |
| Gnomad | rs9364554 |
| Varsome | rs9364554 |
| LitVar | rs9364554 |
| Map | rs9364554 |
| PheGenI | rs9364554 |
| Biobank | rs9364554 |
| 1000 genomes | rs9364554 |
| hgdp | rs9364554 |
| ensembl | rs9364554 |
| geneview | rs9364554 |
| scholar | rs9364554 |
| rs9364554 | |
| pharmgkb | rs9364554 |
| gwascentral | rs9364554 |
| openSNP | rs9364554 |
| 23andMe | rs9364554 |
| SNPshot | rs9364554 |
| SNPdbe | rs9364554 |
| MSV3d | rs9364554 |
| GWAS Ctlg | rs9364554 |
| GMAF | 0.219 |
| Max Magnitude | 0 |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
cancer-genetics these snps influence genetic risk for prostate cancer
- the haplotype rs6983267 rs1016343 rs4242384
- rs7501939
- rs1859962
- rs2660753
- rs9364554
- rs6465657
- rs10993994
- rs7931342
- rs2735839
- rs5945619
- rs10993994
| GWAS | |
|---|---|
| SNP | rs9364554 |
| PubMedID | [PMID 18264097] |
| Condition | Prostate cancer |
| Gene | SLC22A3 |
| Risk Allele | T |
| pValue | 6.00E-010 |
| OR | 1.17 |
| 95% CI | 1.08-1.26 |
[PMID 19336566
] Replication of the 10q11 and Xp11 Prostate Cancer Risk Variants: Results from a Utah Pedigree-Based Study.
[PMID 20651075] Prostate Cancer Susceptibility Variants Confer Increased Risk of Disease Progression
[PMID 21820706] Prostate Cancer Risk Alleles and Their Associations With Other Malignancies
[PMID 18708398] Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.
[PMID 18794092] Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.
[PMID 18974127] Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.
[PMID 19074884] Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
[PMID 19104501] Prostate cancer genomics: towards a new understanding.
[PMID 19318432] Generalizability of associations from prostate cancer genome-wide association studies in multiple populations.
[PMID 19366831] Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
[PMID 19434657] Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
[PMID 19549807] Prostate cancer risk associated loci in African Americans.
[PMID 19639606] Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.
[PMID 20039378] Estimation of genotype relative risks from pedigree data by retrospective likelihoods.
[PMID 20569440] Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.
[PMID 20690139] Meta-analysis of genome-wide and replication association studies on prostate cancer.
[PMID 21390317] Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
[PMID 21520160] Prostate cancer risk variants are not associated with disease progression.
[PMID 21538423] Early onset prostate cancer has a significant genetic component.
[PMID 28272475] SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.
[PMID 29266682] Profile of common prostate cancer risk variants in an unscreened Romanian population.
